ATE163679T1 - Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor - Google Patents

Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor

Info

Publication number
ATE163679T1
ATE163679T1 AT93911148T AT93911148T ATE163679T1 AT E163679 T1 ATE163679 T1 AT E163679T1 AT 93911148 T AT93911148 T AT 93911148T AT 93911148 T AT93911148 T AT 93911148T AT E163679 T1 ATE163679 T1 AT E163679T1
Authority
AT
Austria
Prior art keywords
receptor
vitamin
transcobalamin
blocking agents
growth blocking
Prior art date
Application number
AT93911148T
Other languages
English (en)
Inventor
Alton Charles Morgan Jr
Original Assignee
Receptagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Receptagen Corp filed Critical Receptagen Corp
Application granted granted Critical
Publication of ATE163679T1 publication Critical patent/ATE163679T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93911148T 1992-05-08 1993-05-07 Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor ATE163679T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88054092A 1992-05-08 1992-05-08

Publications (1)

Publication Number Publication Date
ATE163679T1 true ATE163679T1 (de) 1998-03-15

Family

ID=25376514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911148T ATE163679T1 (de) 1992-05-08 1993-05-07 Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor

Country Status (11)

Country Link
US (1) US5688504A (de)
EP (1) EP0644948B1 (de)
JP (1) JPH07508174A (de)
KR (1) KR950701390A (de)
AT (1) ATE163679T1 (de)
AU (1) AU680822B2 (de)
CA (1) CA2135277C (de)
DE (1) DE69317282D1 (de)
NO (1) NO944247L (de)
NZ (1) NZ252559A (de)
WO (1) WO1993023557A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7416728B2 (en) 1992-05-08 2008-08-26 Kyto Biopharma, Inc. Growth blocking agents
US5840880A (en) * 1994-04-08 1998-11-24 Receptagen Corporation Receptor modulating agents
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
DE69528523T2 (de) * 1994-04-08 2003-06-12 Receptagen Corp Rezeptor modulierendes mitteln und entsprechendes verfahren
ATE318844T1 (de) * 1994-09-13 2006-03-15 Kyto Biopharma Inc Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
AU7718296A (en) * 1995-10-19 1997-05-07 Receptagen Corporation Vitamin B12 receptor modulating agents and methods related thereto
US20020102258A1 (en) * 1997-05-12 2002-08-01 Smithkline Beecham Corporation Human tumor necrosis factor receptor-like 2 (TR2) antibodies
EP1009431A4 (de) * 1997-05-12 2000-09-27 Smithkline Beckman Corp Antikörper gegen den menschlichen tumornekrosefaktor-rezeptor des typs 2 (tr2)
US6410245B1 (en) * 1998-04-01 2002-06-25 Affymax, Inc. Compositions and methods for detecting ligand-dependent nuclear receptor and coactivator interactions
GB9820473D0 (en) * 1998-09-18 1998-11-11 Axis Biochemicals Asa Assay
US6492497B1 (en) * 1999-04-30 2002-12-10 Cambridge Antibody Technology Limited Specific binding members for TGFbeta1
JP2005508838A (ja) 2001-03-23 2005-04-07 アフトン コーポレーション 膵癌の組合せ治療
GB0109925D0 (en) * 2001-04-23 2001-06-13 Axis Shield Asa Method
US20090191232A1 (en) * 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
US20040047917A1 (en) * 2002-09-06 2004-03-11 Stephen Wilson Drug delivery and targeting with vitamin B12 conjugates
CA2580965C (en) 2004-09-22 2014-04-08 Receptor Biologix, Inc. Monoclonal antibodies to progastrin
JP2009525274A (ja) * 2006-01-23 2009-07-09 ジョゼフ・ピー・エリコ 標的薬物開発の方法および組成物
US9044461B2 (en) 2006-04-07 2015-06-02 The Research Foundation Of State University Of New York Transcobalamin receptor polypeptides, nucleic acids, and modulators thereof, and related methods of use in modulating cell growth and treating cancer and cobalamin deficiency
JP5524610B2 (ja) 2006-04-07 2014-06-18 ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
CN111050789A (zh) 2017-06-15 2020-04-21 癌症进展有限公司 用于诱导针对肿瘤和癌症的体液免疫和细胞免疫的组合物和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4332785A (en) * 1980-04-09 1982-06-01 University Patents, Inc. Immunoassay for measurement of reticulocytes, and immunoreactive reagents for use therein
JPS633262A (ja) * 1986-06-24 1988-01-08 Toshiba Corp 網状赤血球の分析方法及び装置

Also Published As

Publication number Publication date
NZ252559A (en) 1996-10-28
JPH07508174A (ja) 1995-09-14
CA2135277C (en) 2001-04-24
KR950701390A (ko) 1995-03-23
EP0644948A1 (de) 1995-03-29
CA2135277A1 (en) 1993-11-25
US5688504A (en) 1997-11-18
AU680822B2 (en) 1997-08-14
AU4239193A (en) 1993-12-13
DE69317282D1 (de) 1998-04-09
NO944247D0 (no) 1994-11-07
NO944247L (no) 1995-01-09
EP0644948B1 (de) 1998-03-04
WO1993023557A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
ATE163679T1 (de) Anti-rezeptor antikörper gegen den vitamin b12/transcobalamin ii rezeptor
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
DK0873340T3 (da) Heterocyklisk substituerede cyclopentanforbindelser
EA199700280A1 (ru) Ингибиторы протеинкиназы с
DE69433406D1 (de) Antikörper gegen cd40
TR200100922T2 (tr) Aktif maddelerin akciğerler yolu ile tatbik edilmesi.
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
BR0114646A (pt) anticorpos anti-lt-beta-r humanizados
FI960567A0 (fi) Monoklonaalinen vasta-aine, joka indusoi apoptoosin
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
DK0689426T3 (da) Terapeutisk middel til behandling af melanomer
AU6914798A (en) Compounds and methods for inhibiting the interaction between alpha-catenin and beta-catenin
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
DK0802924T3 (da) Lægemiddel til forlænget immunsuppression og eliminering af tumorceller
ATE318844T1 (de) Wachstumsinhibierende agenzien gegen vitamin b12 bindungsstellen von transcobalamin-ii
DE60007120D1 (de) Isophosphoramide-senfgasanalogen und deren verwendung
TR199900943T2 (xx) Pirimidin t�revlerinin haz�rlanma prosesi.
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
TR199701298T1 (xx) Tetralinler.
FR2694628B1 (fr) Cellule photo-electrique, notamment submersible, et attache rapide pour sa fixation sur une source de lumiere ultraviolette.
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen
ATE217619T1 (de) Endothelin-rezeptor-antagonisten
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
FR2693561B1 (fr) Source de lumière polarisée et rétroprojecteur utilisant cette source.